Inhaled Ciclesonide Study in Preterm Infants

Recruiting now · Phase 1

Conditions studied: Bronchopulmonary Dysplasia

In brief

Our overall objective is to conduct a safety study with inhaled ciclesonide to evaluate known glucocorticoids (sGC)-related acute and intermediate toxic effects while measuring for the first time in neonates its systemic absorption and potential bioactivity (i.e. activation of primary target, the GR, in blood cells).

Key facts

Study ID
NCT06589245
Run by
Venkatesh Sampath
People needed
30
Starts
2025-09-16
Expected to finish
2026-08-31
Last updated by the study team
2026-03-27

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.